Who to call at Pelthos Therapeutics Inc., and when
Fundz watches for the moments Pelthos Therapeutics Inc. starts buying, and tells you who to reach.
- An alert the day Pelthos Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pelthos Therapeutics Inc., from your own LinkedIn network
Pelthos Therapeutics Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
pelthostherapeutics.comAI Executive Summary
AI-powered analysis of 8-K filing content
Pelthos Therapeutics Inc. stockholders approved the 2026 Equity Incentive Plan on September 29, 2026, replacing the 2023 plan to enhance talent retention and competitiveness in the biopharmaceutical industry.
Key Takeaways
The 2026 Equity Incentive Plan was approved by stockholders at the Annual Meeting on September 29, 2026
The new plan replaces the previous 2023 Equity Incentive Plan and became effective immediately upon stockholder approval
2 more takeaways
Related Filings (2)
2 more filings from Pelthos Therapeutics Inc. in the last 90 days
Filing Overview
What This Means
Pelthos Therapeutics Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.